跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Imreb - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Imreb
Approved
STANDARD
Imreb
Gufic Biosciences Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
df9c33ac235f2c9f
Company
Gufic Biosciences Ltd.
Type
Standard
Approval Details
Approval Id
df9c33ac235f2c9f
Drug Approval Philippines Name
Imreb
Product Name
Imreb
Registration Number
DRP-11230
Brand Name
Imreb
Generic Name
Rabeprazole Sodium
Dosage Form
Lyophilized Powder for Intravenous Injection
Dosage Strength
20 mg
Manufacturer
Gufic Biosciences Ltd.
Importer
SRS Life Sciences Inc.
Distributor
Philcare Pharma Inc
Company Detail Path
/organization/gufic-biosciences-ltd
Issuance Date
25 August 2024
Expiry Date
10 October 2029
Pharmacologic Category
Proton Pump Inhibitor
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
df9c33ac235f2c9f
Type
Standard
Back to Philippines FDA Approvals